Table 2.
Causality of immune thrombocytopenia (ITP) incidence after 1 month with virus.
| 0–1 Year | 1.1–5 Year | <5 Year | 5.1–18 Year | |
|---|---|---|---|---|
| HAdV | 0.532 | 0.881 | 0.831 | 0.353 |
| HPIV | 0.619 | 0.560 | 0.992 | 0.869 |
| HRSV | 0.696 | 0.918 | 0.772 | 0.030 |
| IFV | 0.599 | 0.924 | 0.782 | 0.996 |
| HCoV | 0.522 | 0.764 | 0.564 | 0.065 |
| HRV | 0.052 | 0.469 | 0.475 | 0.312 |
| HBoV | 0.493 | 0.489 | 0.960 | 0.887 |
| HMPV | 0.082 | 0.891 | 0.396 | 0.202 |
| Rotavirus | 0.208 | 0.085 | 0.035 | 0.837 |
| Norovirus | 0.832 | 0.571 | 0.873 | 0.079 |
| Adenovirus | 0.385 | 0.486 | 0.319 | 0.482 |
| Astrovirus | 0.646 | 0.871 | 0.169 | 0.029 |
HAdV, human adenovirus; HPIV, human parainfluenza virus; HRSV, human respiratory syncytial virus; IFV, influenza virus; HCoV, human coronavirus; HRV, human rhinovirus; HBoV, human bocavirus; HMPV, human metapneumovirus.